The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Also known as A-fib, atrial fibrillation is an irregular and often fast heart rhythm that can lead to blood clots forming in ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

Higher Heart Rate May Help Spur A-fib in Black Patients By Dennis Thompson HealthDay Reporter TUESDAY, Nov. 5, 2024 (HealthDay News) -- An elevated heart rate could provide an important clue to ...

WICHITA, Kan. (KSNW) — Via Christi says it is the first hospital in the region to perform a new procedure for atrial ...

The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the ...

But new research finds that on extremely hot days, people with the devices face nearly triple the odds for a dangerous arrhythmia known as atrial fibrillation, compared to days with cooler ...

Atrial Fibrillation (AF) is the most common sustained ... guided by simple and widely available monitoring tools to confirm compliance and response to therapy, has consistently improved outcomes.

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Every 10-beat-per-minute increase in resting heart rate is linked to a 9% higher risk of A-fib A-fib greatly increases risk of stroke and heart disease TUESDAY, Nov. 5, 2024 (HealthDay News ...